| Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome (NCT05444946) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2022-06-15 |
| Pharmacological Evaluation of Antifungal in Chronic Pulmonary Aspergillosis (NCT05064605) | Assistance Publique - Hôpitaux de Paris | 2021-10-01 |
| A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis (NCT04824417) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2021-03-01 |
| Pulmonary Aspergillosis in Tuberculosis Patients (NCT05045391) | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 2020-01-01 |
| Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA (NCT03920527) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2019-07-01 |
| Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole (NCT03656081) | Poitiers University Hospital | 2018-12-19 |
| Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (NCT03059992) | Scynexis, Inc. | 2017-04-01 |
| Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA)-Multicenter Study (NCT03027089) | Chinese PLA General Hospital | 2017-01-01 |
| Impact of A. Lumbricoides on Pulmonary Aspergillosis Development (NCT05783544) | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 2015-05-01 |
| Vitamin D and Immune Response in Pulmonary Tuberculosis With and Without Chronic Pulmonary Aspergillosis (NCT07516158) | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 2015-01-01 |
| Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis (NCT05897294) | TFF Pharmaceuticals, Inc. | |